Everyone is Encouraged to Get Their Third Vaccine

Community NewsNews
388

Translate to Spanish or other 102 languages!

Texas Border Business/Mega Doctor News Image
Texas Border Business/Mega Doctor News Image

Mega Doctor News

- Advertisement -

Today, Roberto Hugo Gonzalez, Publisher of Texas Border Business and Mega Doctor News, received his Moderna booster shot. This is the third vaccine in a series which aids in the prevention of COVID-19. He encourages everyone to get their booster shot as soon as possible. Whether you have received Moderna or Pfizer, they are readily available and always at no cost.  

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
“Turn It Off” to Help Mental Health
Next article
COVID-19 boosters offered to anyone ages 18 and older

More Articles

DHR Health To Add Advanced Vascular Care Services to Its Brownsville Multispecialty Clinic

Beginning August 31, 2026, patients living in the lower Rio Grande Valley, will have access to advanced vascular surgical services at the DHR Health Brownsville Multispecialty Clinic, located next to its hospital, DHR Health Brownsville, at 4770 N. Expressway.

CDC Issues Warning Over Multistate Salmonella Outbreak Linked to Jalapeños

The Centers for Disease Control and Prevention (CDC) has issued a food safety alert following a multistate outbreak of Salmonella infections linked to contaminated jalapeño peppers

ER 24/7 Brownsville – Grand Opening & Ribbon Cutting Ceremony, Aug. 6th

The Brownsville Chamber of Commerce and its Bienvenidos Committee are excited to announce the Grand Opening of ER 24/7 Brownsville today, August 6, 2026, at 3:00 PM. This celebration will take place at 449 E. Alton Gloor Blvd in Brownsville, Texas. 

New Blood Test Spots Early Signs of Immunotherapy Effectiveness

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy determined that liquid biopsy—a blood test that detects circulating tumor DNA (ctDNA)—can predict, within a few weeks, whether patients with advanced non-small cell lung cancer are benefiting from immunotherapy.
- Advertisement -